Roivant Sciences Ltd. · NASDAQ:ROIV
Sukhatme Mayukh sold 664,826 Roivant Sciences Ltd. shares (Form 4)
Traded Aug 14 to Aug 18, 2026 · Filed Aug 18, 2026
From Aug 14 to Aug 18, 2026, Sukhatme Mayukh (Director, President & CIO) sold 664,826 Roivant Sciences Ltd. shares at an average US$36.34 for US$24.2M, leaving 18,630,739 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 664,826 shares
- Price
- US$36.34 average (US$36.23 to US$37.18)
- Value
- US$24.2M
- Holding after
- 18,630,739 shares
- Trading plan
- No
- Role
- Director, President & CIO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Shares | Option exercise | 243,177 | US$3.85 | 18,873,916 | Direct |
| Aug 14, 2026 | Common Shares | Sale | 243,177 | US$36.23 | 18,630,739 | Direct |
| Aug 17, 2026 | Common Shares | Option exercise | 284,707 | US$3.85 | 18,915,446 | Direct |
| Aug 17, 2026 | Common Shares | Sale | 284,707 | US$36.25 | 18,630,739 | Direct |
| Aug 18, 2026 | Common Shares | Option exercise | 105,141 | US$3.85 | 18,735,880 | Direct |
| Aug 18, 2026 | Common Shares | Sale | 105,141 | US$36.59 | 18,630,739 | Direct |
| Aug 18, 2026 | Common Shares | Option exercise | 31,801 | US$3.85 | 18,662,540 | Direct |
| Aug 18, 2026 | Common Shares | Sale | 31,801 | US$37.18 | 18,630,739 | Direct |
Source
Related
- Roivant Sciences Ltd.
- Sukhatme Mayukh
- Roivant Sciences Ltd. shareholders
- Form 4 · Sukhatme Mayukh · Oct 2, 2026
- Form 4 · Sukhatme Mayukh · Aug 21, 2026
- Form 4 · Sukhatme Mayukh · Jul 2, 2026
- Form 4 · Sukhatme Mayukh · Jun 29, 2026
- Form 4 · Sukhatme Mayukh · Apr 1, 2026
- Form 4 · Epperly Melissa B, · Oct 5, 2026
- Form 4 · Gline Matthew · Oct 2, 2026
- Form 4 · Venker Eric · Oct 2, 2026
- Form 4 · Torti Frank · Oct 2, 2026
- Form 4 · Pulik Richard · Sep 22, 2026